1. Home
  2. KMDA vs DDL Comparison

KMDA vs DDL Comparison

Compare KMDA & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • DDL
  • Stock Information
  • Founded
  • KMDA 1990
  • DDL 2014
  • Country
  • KMDA Israel
  • DDL China
  • Employees
  • KMDA N/A
  • DDL N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • KMDA Health Care
  • DDL Consumer Discretionary
  • Exchange
  • KMDA Nasdaq
  • DDL Nasdaq
  • Market Cap
  • KMDA 399.7M
  • DDL 457.4M
  • IPO Year
  • KMDA N/A
  • DDL 2021
  • Fundamental
  • Price
  • KMDA $7.74
  • DDL $2.06
  • Analyst Decision
  • KMDA Strong Buy
  • DDL
  • Analyst Count
  • KMDA 3
  • DDL 0
  • Target Price
  • KMDA $14.67
  • DDL N/A
  • AVG Volume (30 Days)
  • KMDA 83.7K
  • DDL 442.7K
  • Earning Date
  • KMDA 08-13-2025
  • DDL 08-06-2025
  • Dividend Yield
  • KMDA 2.56%
  • DDL N/A
  • EPS Growth
  • KMDA 31.21
  • DDL N/A
  • EPS
  • KMDA 0.28
  • DDL 0.18
  • Revenue
  • KMDA $167,235,000.00
  • DDL $3,241,404,122.00
  • Revenue This Year
  • KMDA $14.51
  • DDL $8.80
  • Revenue Next Year
  • KMDA $9.31
  • DDL $11.75
  • P/E Ratio
  • KMDA $27.53
  • DDL $11.24
  • Revenue Growth
  • KMDA 11.83
  • DDL 17.62
  • 52 Week Low
  • KMDA $4.93
  • DDL $1.62
  • 52 Week High
  • KMDA $9.16
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 66.78
  • DDL 45.55
  • Support Level
  • KMDA $7.68
  • DDL $1.99
  • Resistance Level
  • KMDA $7.86
  • DDL $2.29
  • Average True Range (ATR)
  • KMDA 0.21
  • DDL 0.08
  • MACD
  • KMDA 0.05
  • DDL 0.01
  • Stochastic Oscillator
  • KMDA 67.61
  • DDL 21.67

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: